Elisa V Bandera1,2,3, Bo Qin1,3, Yong Lin1,2, Nur Zeinomar1,3, Baichen Xu1, Dhanya Chanumolu1,3, Adana A M Llanos1,2, Coral O Omene3, Karen S Pawlish4, Christine B Ambrosone5, Kitaw Demissie6, Chi-Chen Hong5. 1. Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick. 2. Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey. 3. Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick. 4. Cancer Epidemiology Services, New Jersey State Cancer Registry, Trenton. 5. Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York. 6. Department of Epidemiology and Biostatistics, SUNY Downstate Health Sciences University, School of Public Health, Brooklyn, New York.
Abstract
IMPORTANCE: Obesity disproportionately affects Black women, who also have a higher risk of death after a breast cancer diagnosis compared with women of other racial/ethnic groups. However, few studies have evaluated the association of measures of adiposity with mortality among Black breast cancer survivors. OBJECTIVE: To assess the association of measures of adiposity with survival after a breast cancer diagnosis among Black women. DESIGN, SETTING, AND PARTICIPANTS: This prospective population-based cohort study comprised 1891 women with stage 0 to IV breast cancer who self-identified as African American or Black and were ages 20 to 75 years. The New Jersey State Cancer Registry was used to identify women living in 10 counties in New Jersey who were recruited from March 1, 2006, to February 29, 2020, and followed up until September 2, 2020. EXPOSURES: Measures of adiposity, including body mass index, body fat distribution (waist circumference and waist-to-hip ratio), and body composition (percent body fat and fat mass index), were collected during in-person interviews at approximately 10 months after breast cancer diagnosis. MAIN OUTCOMES AND MEASURES: All-cause and breast cancer-specific mortality. RESULTS: Among 1891 women, the mean (SD) age at breast cancer diagnosis was 54.5 (10.8) years. During a median follow-up of 5.9 years (range, 0.5-14.8 years), 286 deaths were identified; of those, 175 deaths (61.2%) were associated with breast cancer. A total of 1060 women (56.1%) had obesity, and 1291 women (68.3%) had central obesity. Higher adiposity, particularly higher waist-to-hip ratio, was associated with worse survival. Women in the highest quartile of waist-to-hip ratio had a 61% increased risk of dying from any cause (hazard ratio [HR], 1.61; 95% CI, 1.12-2.33) and a 68% increased risk of breast cancer death (HR, 1.68; 95% CI, 1.04-2.71) compared with women in the lowest quartile. The risks of all-cause and breast cancer-specific death were similarly high among women in the highest quartile for waist circumference (HR, 1.74 [95% CI, 1.26-2.41] and 1.64 [95% CI, 1.08-2.48], respectively), percent body fat (HR, 1.53 [95% CI, 1.09-2.15] and 1.81 [95% CI, 1.17-2.80]), and fat mass index (HR, 1.57 [95% CI, 1.11-2.22] and 1.74 [95% CI, 1.10-2.75]); however, the risk was less substantial for body mass index (HR, 1.26 [95% CI, 0.89-1.79] and 1.33 [95% CI, 0.84-2.10]). In analyses stratified by estrogen receptor status, menopausal status, and age, a higher waist-to-hip ratio was associated with a higher risk of all-cause death among women who had estrogen receptor-negative tumors (HR, 2.24; 95% CI, 1.14-4.41), women who were postmenopausal (HR, 2.15; 95% CI, 1.28-3.61), and women who were 60 years or older at diagnosis (HR per 0.10-U increase, 1.76; 95% CI, 1.37-2.26). CONCLUSIONS AND RELEVANCE: In this population-based cohort study, central obesity and higher adiposity were associated with higher all-cause and breast cancer-specific mortality among Black breast cancer survivors. Simple measures of body fat distribution and body composition were found to be useful tools for identifying Black women with a higher risk of death after a breast cancer diagnosis.
IMPORTANCE: Obesity disproportionately affects Black women, who also have a higher risk of death after a breast cancer diagnosis compared with women of other racial/ethnic groups. However, few studies have evaluated the association of measures of adiposity with mortality among Black breast cancer survivors. OBJECTIVE: To assess the association of measures of adiposity with survival after a breast cancer diagnosis among Black women. DESIGN, SETTING, AND PARTICIPANTS: This prospective population-based cohort study comprised 1891 women with stage 0 to IV breast cancer who self-identified as African American or Black and were ages 20 to 75 years. The New Jersey State Cancer Registry was used to identify women living in 10 counties in New Jersey who were recruited from March 1, 2006, to February 29, 2020, and followed up until September 2, 2020. EXPOSURES: Measures of adiposity, including body mass index, body fat distribution (waist circumference and waist-to-hip ratio), and body composition (percent body fat and fat mass index), were collected during in-person interviews at approximately 10 months after breast cancer diagnosis. MAIN OUTCOMES AND MEASURES: All-cause and breast cancer-specific mortality. RESULTS: Among 1891 women, the mean (SD) age at breast cancer diagnosis was 54.5 (10.8) years. During a median follow-up of 5.9 years (range, 0.5-14.8 years), 286 deaths were identified; of those, 175 deaths (61.2%) were associated with breast cancer. A total of 1060 women (56.1%) had obesity, and 1291 women (68.3%) had central obesity. Higher adiposity, particularly higher waist-to-hip ratio, was associated with worse survival. Women in the highest quartile of waist-to-hip ratio had a 61% increased risk of dying from any cause (hazard ratio [HR], 1.61; 95% CI, 1.12-2.33) and a 68% increased risk of breast cancer death (HR, 1.68; 95% CI, 1.04-2.71) compared with women in the lowest quartile. The risks of all-cause and breast cancer-specific death were similarly high among women in the highest quartile for waist circumference (HR, 1.74 [95% CI, 1.26-2.41] and 1.64 [95% CI, 1.08-2.48], respectively), percent body fat (HR, 1.53 [95% CI, 1.09-2.15] and 1.81 [95% CI, 1.17-2.80]), and fat mass index (HR, 1.57 [95% CI, 1.11-2.22] and 1.74 [95% CI, 1.10-2.75]); however, the risk was less substantial for body mass index (HR, 1.26 [95% CI, 0.89-1.79] and 1.33 [95% CI, 0.84-2.10]). In analyses stratified by estrogen receptor status, menopausal status, and age, a higher waist-to-hip ratio was associated with a higher risk of all-cause death among women who had estrogen receptor-negative tumors (HR, 2.24; 95% CI, 1.14-4.41), women who were postmenopausal (HR, 2.15; 95% CI, 1.28-3.61), and women who were 60 years or older at diagnosis (HR per 0.10-U increase, 1.76; 95% CI, 1.37-2.26). CONCLUSIONS AND RELEVANCE: In this population-based cohort study, central obesity and higher adiposity were associated with higher all-cause and breast cancer-specific mortality among Black breast cancer survivors. Simple measures of body fat distribution and body composition were found to be useful tools for identifying Black women with a higher risk of death after a breast cancer diagnosis.
Authors: Shannon M Conroy; Gertraud Maskarinec; Lynne R Wilkens; Kami K White; Brian E Henderson; Laurence N Kolonel Journal: Breast Cancer Res Treat Date: 2011-04-16 Impact factor: 4.872
Authors: Elisa V Bandera; Stephanie H Fay; Edward Giovannucci; Michael F Leitzmann; Rachel Marklew; Anne McTiernan; Amy Mullee; Isabelle Romieu; Inger Thune; Ricardo Uauy; Martin J Wiseman Journal: Int J Cancer Date: 2016-07-13 Impact factor: 7.396
Authors: Hyuna Sung; Rebecca L Siegel; Lindsey A Torre; Jonathan Pearson-Stuttard; Farhad Islami; Stacey A Fedewa; Ann Goding Sauer; Kerem Shuval; Susan M Gapstur; Eric J Jacobs; Edward L Giovannucci; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-12-12 Impact factor: 508.702
Authors: Stephanie M George; Leslie Bernstein; Ashley W Smith; Marian L Neuhouser; Kathy B Baumgartner; Richard N Baumgartner; Rachel Ballard-Barbash Journal: Breast Cancer Res Treat Date: 2014-07-24 Impact factor: 4.872
Authors: Rebecca J Cleveland; Sybil M Eng; Page E Abrahamson; Julie A Britton; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-09 Impact factor: 4.254
Authors: Katherine M Flegal; John A Shepherd; Anne C Looker; Barry I Graubard; Lori G Borrud; Cynthia L Ogden; Tamara B Harris; James E Everhart; Nathaniel Schenker Journal: Am J Clin Nutr Date: 2008-12-30 Impact factor: 7.045
Authors: Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John W Graves; Martha N Hill; Daniel H Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella Journal: J Clin Hypertens (Greenwich) Date: 2005-02 Impact factor: 3.738
Authors: Adana A M Llanos; John B Aremu; Ting-Yuan David Cheng; Wenjin Chen; Marina A Chekmareva; Elizabeth M Cespedes Feliciano; Bo Qin; Yong Lin; Coral Omene; Thaer Khoury; Chi-Chen Hong; Song Yao; Christine B Ambrosone; Elisa V Bandera; Kitaw Demissie Journal: Front Endocrinol (Lausanne) Date: 2022-06-29 Impact factor: 6.055
Authors: Mmadili N Ilozumba; Song Yao; Adana A M Llanos; Angela R Omilian; Weizhou Zhang; Susmita Datta; Chi-Chen Hong; Warren Davis; Thaer Khoury; Elisa V Bandera; Michael Higgins; Christine B Ambrosone; Ting-Yuan David Cheng Journal: Discov Oncol Date: 2022-05-24
Authors: Bo Qin; Kate Kim; Noreen Goldman; Andrew G Rundle; Dhanya Chanumolu; Nur Zeinomar; Baichen Xu; Karen S Pawlish; Christine B Ambrosone; Kitaw Demissie; Chi-Chen Hong; Gina S Lovasi; Elisa V Bandera Journal: J Clin Oncol Date: 2022-03-25 Impact factor: 50.717